secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001005286-24-000081
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore settles proxy fight with 22NW, adds four new directors and declassification proposal
--------------------------------------------------------------------------------

- 22NW withdraws director nominations and special meeting demand; board declassification proposal at 2023 annual meeting.
- Four new directors appointed: Humberto Antunes, Jason Aryeh, Paul Johnson, Matthew Korenberg.
- Standstill agreements with 22NW, Legion, Wynnefield through 2025 annual meeting.
- Board size to reduce to 8 pre-AGM, expand to 11 post-AGM, then back to 9 by Nov 2024.
- Three investor groups collectively own ~43.5% of voting securities on as-converted basis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000081/0001005286-24-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000081/lndc-20240628.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer